Skip to main navigation

Overview
News & Events
- News Releases
- Events
Stock Information
Financial & Filings
Governance
Investor Resources

News Releases

Year

04 Oct '22

Bionano Genomics Announces Publication of Study from Sorbonne Université Showing that WGS Identified only 63% of Structural Variations that OGM Detected in Liver Cancer

26 Sep '22

Bionano Laboratories to Provide Enhanced Genetic Counseling and Patient Care for Genetic Disorders with OptraHEALTH’s HealthFAX™

23 Sep '22

Bionano Genomics Announces Launch of CLIA-Certified Bionano Laboratories, and Expands its Clinical Testing Menu with Launch of First OGM-Based LDT for FSHD

21 Sep '22

Bionano Genomics Announces Publication of Study Using OGM for Detection of Balanced Chromosomal Rearrangements Found in Recurrent Pregnancy Loss

14 Sep '22

Bionano Genomics Announces Publication of Study in MDS and AML Showing Utility for Refined Diagnostics and Prognostic Stratification

08 Sep '22

Bionano Genomics Announces Publication of Study Demonstrating Utility of OGM as Part of a Comprehensive Workflow for Quality Evaluation of Human Induced Pluripotent Stem Cells (iPSCs)

07 Sep '22

Bionano Genomics to Participate at the H.C. Wainwright 24th Annual Global Investment Conference

25 Aug '22

Bionano Genomics Announces the First Publication Using OGM to Analyze Impact of Chromothripsis and TP53 Abnormalities on Chronic Lymphocytic Leukemia (CLL) Patients with High Genomic Complexity

11 Aug '22

Bionano Genomics Announces First Publication Using OGM for Detection of Repeat Expansions in CANVAS and Adult-Onset Ataxia

04 Aug '22

Bionano Genomics Reports Second Quarter 2022 Financial Results and Highlights Recent Business Progress

Current page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Next page
Last page

Displaying 1 - 10 of 60

Print Page
Email Alerts
RSS Feeds

Request Email Alerts

© 2022 Bionano Genomics, Inc. All rights reserved. For Research Use Only. Not For Use In Diagnostic Procedures. | Legal Notice | Privacy Policy